Tag: Option Care Health

BANNOCKBURN, Ill., and MONTREAL – Option Care Health and AlayaCare have established a technology collaboration to develop software for alternate site infusion therapy.   This effort builds on an existing relationship, under which Option Care Health, a provider of home and alternate site infusion services, uses AlayaCare’s existing home and community care software to manage its clinical resources at the point of care.   “The patient experience is at the forefront...

NORTHFIELD, Ill. – Medline Industries has entered into an agreement to receive a majority investment from a group of private equity firms, including Blackstone, Carlyle Group and Hellman & Friedman, worth a reported $30-plus billion.  Medline, which generated revenues of $17.5 billion in 2020, will use the new resources from the partnership to expand its product offerings, accelerate international expansion and continue to make new infrastructure investments to strengthen its global...

Apria has announced a price to the public of $27 per share for a previously announced secondary offering of 4.5 million shares of common stock by a selling stockholder affiliated with Blackstone. The selling stockholder has also granted the underwriters a 30-day option to purchase up to 675,000 additional shares of common stock. The offering is expected to close on June 14, 2021, subject to customary closing conditions…Option Care Health has announced that an affiliate of Madison Dearborn...

BANNOCKBURN, Ill. – With a tuck-in acquisition in the Southeast, a new state-of-the-art facility in Chicago and new therapies added to its chronic care portfolio, Option Care Health is laying the groundwork for sustainable growth, say company officials.  Option Care announced May 6 it had paid $18.5 million for Houston-based BioCureRx, a regional provider of certain chronic care therapies.  “While limited in size, the BioCure transaction signifies...

BANNOCKBURN, Ill. – Option Care Health reported revenue of $759.2 million for the first quarter of 2021, an increase of 7.6% compared to $705.4 million for the same period last year.   Gross profit was $165.5 million, or 21.8% of net revenue, and adjusted EBITDA was $52.2 million for the quarter.  “The Option Care Health team delivered solid financial results in the first quarter while continuing to lay the foundation for sustained growth,” said John Rademacher,...

BANNOCKBURN, Ill. – Option Care Health saw double-digit growth in revenues as the company took advantage of its technology platform to respond to the disruption caused by the COVID-19 pandemic, said CEO John Rademacher on a recent earnings call.  Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019.  “Our ability to quickly pivot and utilize our technology...

BANNOCKBURN, Ill. – Option Care Health has agreed to sell 12 million shares of the company’s common stock at $20 per share in an underwritten public offering. The selling stockholder, an affiliate of Madison Dearborn Partners, also granted the underwriter a 30-day option to purchase up to 1.8 million additional shares of common stock. The offering is expected to close today, March 17. This sale of shares represents approximately 6.7% of the current shares outstanding. Option Care...

BANNOCKBURN, Ill. – Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019. Net revenues for the full year were about $3 billion, an increase of 31.3% compared to the full year 2019. Adjusted EBITDA for the quarter was $67.7 million, and $221.7 million for the full year, up 27.7% and 69.5%, respectively. “I am incredibly proud of the effort and execution by the Option Care Health team in...

BATON ROUGE, La., and BANNOCKBURN, Ill. – Option Care Health has partnered with Amedisys, a provider of home health, hospice and personal care, to provide COVID antibody infusion therapy in skilled nursing and assisted living facilities. In December, the National Home Infusion Association announced a pilot program with Operation Warp Speed and the Department of Health and Human Services to expand access to Bamlanivimab, which is being used to treat mild to moderate COVID-19 in adults and pediatrics...

BANNOCKBURN, Ill. - Option Care Health has been chosen to participate in a limited distribution network for VILTEPSO (viltolarsen) for patients with Duchenne Muscular Dystrophy who are amenable to exon 53 skipping therapy. Viltepso is among a growing number of chronic infusion therapies for neuromuscular disorders that Option Care Health is able to deliver to patients at home or in one of the company's more than 125 ambulatory infusion suites across the country. “Our demonstrated track record...